KOD Stock Analysis: Buy, Sell, or Hold?
KOD - Kodiak Sciences Inc Common Stock
$38.33
-1.51 (-3.79%)
▼
5d:
-7.3%
30d:
-6.56%
90d:
+2.46%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Aug 17, 2026 at $40.98 · last confirmed Aug 21, 2026
Strength: 7.5/10
Get Alerted When KOD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: KOD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: KOD shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: KOD is currently trading at $38.33, which is considered oversold relative to its 30-day fair value range of $40.08 to $43.31.
Technical Outlook: Technically, KOD is showing sideways momentum. Immediate support is located at $36.35, while resistance sits at $46.09. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: KOD scores 22/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $69.00 (+80.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KOD is showing sideways momentum. Immediate support is located at $36.35, while resistance sits at $46.09. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: KOD scores 22/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $69.00 (+80.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$40.08 -
$43.31
Company Quality Score
42/100
(HOLD)
Options IV Signal
42th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
56.2%
Protect Your Profits
Holding KOD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 42th percentile)
- BEARISH: Weak technical setup (22/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.8%)
- BULLISH: Trading 80.0% below Wall St target ($69.00)
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$40.08 -
$43.31
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$7.89
(20.6%)
Support & Resistance Levels
Support Level
$36.35
Resistance Level
$46.09
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.81
Wall Street Target
$69.00
(+80.0%)
Share & Embed Analysis
Last updated: August 23, 2026 9:47 AM ET
Data refreshes hourly during market hours. Next update: 10:47 AM
Data refreshes hourly during market hours. Next update: 10:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KOD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 33 SELL |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 26 SELL |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$840 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 55 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 49 HOLD |
Advanced KOD Option Strategies
Professional options setups generated by AI based on today's KOD price and gamma walls.
